Northwestern Memorial Hospital

Northwestern Memorial Hospital was paid $1.79M by Medicaid between Jan 2018 and Aug 2024, across 184 billing codes. Its largest line is 87389, Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies — 7.3% of everything it billed.

33Billing provider infoNORTHWESTERN MEMORIAL HOSPITAL
CHICAGO, IL 60611

33aNPI1497859649assigned 09/09/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$1.79M

24GClaims307,140

24DCodes billed184

24AFirst – last monthJan 2018 – Aug 2024

Compared with peers

Next to other General Acute Care Hospital providers in Illinois

Rank by total paid#32 of 129

Median peer was paid$547K

This provider vs. median3.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	107,330	$568K
2019	138,861	$823K
2020	59,127	$373K
2021	432	$8K
2022	468	$9K
2023	731	$13K
2024incomplete	191	$376.14

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	7.3%	5,572	4,794	$130K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	7.2%	145	132	$129K
77067	Screening mammography, bilateral, including computer-aided detection	5.7%	1,961	1,870	$102K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	5.4%	6,595	5,224	$96K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	5.2%	6,578	5,215	$93K
80053	Comprehensive metabolic panel	4.0%	24,394	17,301	$72K
J7297	Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg	3.9%	97	82	$71K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	3.2%	5,245	3,019	$58K
87536		3.2%	1,413	889	$57K
84443	Thyroid stimulating hormone (TSH)	3.0%	9,336	8,104	$54K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	3.0%	1,713	1,194	$53K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.0%	26,322	18,092	$35K

172 more codes

87497		1.8%	1,831	$32K
99214	Doctor's office visit, returning patient (more involved)	1.8%	657	$32K
88305	Level IV - Surgical pathology, gross and microscopic examination	1.5%	1,158	$28K
99285	Emergency room visit (most serious)	1.5%	221	$27K
86480		1.5%	1,260	$26K
86780		1.3%	5,553	$23K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.2%	2,011	$21K
83883		1.2%	2,665	$21K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.2%	976	$21K
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	1.2%	973	$21K
80180		1.1%	1,103	$20K
87086	Culture, bacterial; quantitative colony count, urine	1.1%	6,023	$19K
82784		1.0%	2,567	$18K
36415	Collection of venous blood by venipuncture	<1%	15,657	$16K
86235		<1%	1,446	$16K
86334		<1%	1,512	$16K
87799		<1%	568	$16K
71046	Radiologic examination, chest; 2 views	<1%	1,596	$15K
80048	Basic metabolic panel (calcium, ionized)	<1%	5,029	$14K
83970		<1%	1,035	$14K
82607		<1%	3,981	$14K
H0004	Behavioral health counseling and therapy, per 15 minutes	<1%	399	$14K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,962	$13K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	562	$12K
87522	Neg quan hep c or qual rna	<1%	497	$11K
86803		<1%	2,425	$11K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	5,021	$11K
88112		<1%	275	$10K
87340		<1%	3,596	$10K
80197		<1%	2,698	$9K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	60	$9K
84403		<1%	851	$9K
85027		<1%	6,838	$8K
86160		<1%	1,668	$8K
90686		<1%	499	$8K
80061	Lipid panel	<1%	6,231	$8K
83036	Hemoglobin; glycosylated (A1C)	<1%	6,386	$7K
83735		<1%	4,916	$7K
87186		<1%	1,666	$7K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	398	$7K
86147		<1%	751	$7K
83615		<1%	4,800	$6K
83880		<1%	1,111	$6K
86038		<1%	1,190	$6K
82728		<1%	4,142	$6K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	2,961	$5K
87529		<1%	198	$5K
81001		<1%	6,949	$5K
87081		<1%	2,165	$5K
84153		<1%	932	$5K
82105		<1%	871	$4K
84165		<1%	1,660	$4K
83516		<1%	853	$4K
84466		<1%	1,933	$4K
83540		<1%	3,463	$4K
86850		<1%	2,986	$4K
86704		<1%	1,166	$4K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	181	$4K
82746		<1%	1,658	$4K
83001		<1%	589	$4K
86225		<1%	1,226	$4K
86706		<1%	1,181	$4K
86140		<1%	3,369	$4K
86360		<1%	1,231	$4K
84439		<1%	2,596	$3K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	446	$3K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	546	$3K
87517		<1%	137	$3K
86901		<1%	3,144	$3K
99284	Emergency room visit (serious)	<1%	30	$3K
87220		<1%	2,787	$3K
80076		<1%	1,396	$3K
84550		<1%	3,263	$3K
87210		<1%	2,738	$3K
84100		<1%	2,933	$3K
99201		<1%	147	$3K
80069		<1%	1,300	$3K
86787		<1%	528	$3K
86359		<1%	1,234	$3K
87205		<1%	3,689	$3K
85610		<1%	3,599	$3K
84702		<1%	1,016	$3K
83550		<1%	1,522	$3K
82232		<1%	1,228	$2K
86900		<1%	3,150	$2K
82570		<1%	2,089	$2K
95800		<1%	29	$2K
86039		<1%	837	$2K
87077		<1%	1,048	$2K
86762		<1%	1,362	$2K
84146		<1%	579	$2K
87088		<1%	609	$2K
83520		<1%	357	$2K
86790		<1%	325	$2K
82670		<1%	567	$2K
87070		<1%	1,081	$2K
86769		<1%	57	$2K
81268		<1%	19	$2K
82951		<1%	271	$1K
87493		<1%	74	$1K
83020		<1%	577	$1K
85652		<1%	2,392	$1K
85730		<1%	880	$1K
82378		<1%	248	$1K
87075		<1%	231	$1K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	14	$1K
82550		<1%	747	$1K
82950		<1%	1,056	$1K
81267		<1%	32	$1K
84480		<1%	633	$1K
82043		<1%	1,174	$1K
84156		<1%	2,042	$993.72
G0008	Administration of influenza virus vaccine	<1%	294	$984.63
83690		<1%	558	$922.23
86256		<1%	295	$846.24
87184		<1%	282	$804.64
84402		<1%	189	$779.40
83002		<1%	341	$778.47
86592		<1%	695	$773.33
86765		<1%	465	$763.74
86304		<1%	90	$745.58
84481		<1%	339	$718.15
82565		<1%	519	$712.72
86431		<1%	442	$704.70
73630		<1%	84	$670.68
86146		<1%	18	$659.94
86200		<1%	237	$657.14
84425		<1%	136	$647.99
86317		<1%	91	$589.00
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	14	$535.12
87486		<1%	60	$512.45
87581		<1%	60	$490.16
86800		<1%	204	$448.23
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	78	$440.60
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	19	$435.01
85045		<1%	708	$404.79
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	19	$402.96
82533		<1%	114	$402.65
86255		<1%	142	$357.50
77077		<1%	12	$344.06
88342		<1%	52	$296.01
86644		<1%	61	$292.04
84630		<1%	127	$282.10
82248		<1%	279	$275.96
82150		<1%	171	$268.31
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	26	$221.20
87045		<1%	76	$193.58
72100		<1%	13	$169.09
85379		<1%	91	$165.89
87338		<1%	18	$164.09
73030		<1%	16	$141.62
81003		<1%	221	$140.28
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	18	$130.14
80177		<1%	57	$121.68
84154		<1%	20	$116.10
86665		<1%	13	$112.60
82952		<1%	150	$95.70
84681		<1%	19	$87.36
84703		<1%	51	$87.02
82040		<1%	63	$79.98
85007		<1%	112	$67.94
87177		<1%	52	$63.72
86677		<1%	15	$59.20
85651		<1%	35	$52.00
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	76	$48.50
87102		<1%	17	$36.24
81025		<1%	17	$35.30
87046		<1%	76	$31.98
87206		<1%	40	$30.60
82390		<1%	15	$30.17
86709		<1%	13	$19.04
G0476	Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test	<1%	159	$7.81

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialORSINI, JOHN (VICE PRESIDENT OF FINANCE)

Parent organizationNORTHWESTERN MEMORIAL HEALTHCARE